- Public Comps
- SKAN Group
SKAN Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for SKAN Group and similar public comparables like Nakanishi, Enovis, Savaria, Cofoe Medical and more.
SKAN Group Overview
About SKAN Group
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, and transfer systems. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
Founded
1968
HQ

Employees
1.5K
Website
Financials (LTM)
EV
$1.6B
Valuation Multiples
Start free trialSKAN Group Financials
SKAN Group reported last 12-month revenue of $455M and EBITDA of $57M.
In the same LTM period, SKAN Group generated $358M in gross profit, $57M in EBITDA, and $28M in net income.
Revenue (LTM)
SKAN Group P&L
In the most recent fiscal year, SKAN Group reported revenue of $421M and EBITDA of $49M.
SKAN Group is profitable as of last fiscal year, with gross margin of 75%, EBITDA margin of 12%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
SKAN Group Stock Performance
SKAN Group has current market cap of $1.6B, and enterprise value of $1.6B.
Market Cap Evolution
SKAN Group's stock price is $69.73.
SKAN Group share price increased by 1.8% in the last 30 days, and decreased by 26.8% in the last year.
SKAN Group has an EPS (earnings per share) of $0.99.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.6B | 0.1% | 1.8% | 20.9% | -26.8% | $0.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSKAN Group Valuation Multiples
SKAN Group trades at 3.5x EV/Revenue multiple, and 28.1x EV/EBITDA.
EV / Revenue (LTM)
SKAN Group Financial Valuation Multiples
As of July 19, 2026, SKAN Group has market cap of $1.6B and EV of $1.6B.
SKAN Group has a P/E ratio of 56.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SKAN Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SKAN Group Margins & Growth Rates
SKAN Group grew revenue by 15% and EBITDA by 32% in the last fiscal year.
In the most recent fiscal year, SKAN Group reported gross margin of 75%, EBITDA margin of 12%, and net margin of 5%.
SKAN Group Margins
SKAN Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SKAN Group Operational KPIs
SKAN Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
SKAN Group's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SKAN Group's Rule of X is 56% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SKAN Group Competitors
SKAN Group competitors include Nakanishi, Enovis, Savaria, Cofoe Medical, Nihon Kohden, Beijing Balance Medical, MicroPort Scientific, MicroPort, El.En. Group and Integra Lifesciences.
Most SKAN Group public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.6x | 2.5x | 10.7x | 10.2x | |||
| 1.3x | 1.3x | 7.3x | 7.0x | |||
| 2.6x | 2.5x | 12.6x | 12.2x | |||
| 2.7x | 2.4x | 14.7x | 13.3x | |||
| 0.9x | 1.0x | 8.7x | 8.8x | |||
| 17.4x | - | 43.1x | - | |||
| 2.2x | 2.1x | 15.2x | 11.4x | |||
| 6.7x | 5.9x | 12.2x | 11.0x | |||
This data is available for Pro users. Sign up to see all SKAN Group competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SKAN Group
| When was SKAN Group founded? | SKAN Group was founded in 1968. |
| Where is SKAN Group headquartered? | SKAN Group is headquartered in Switzerland. |
| How many employees does SKAN Group have? | As of today, SKAN Group has over 1K employees. |
| Who is the CEO of SKAN Group? | SKAN Group's CEO is Thomas Huber. |
| Is SKAN Group publicly listed? | Yes, SKAN Group is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of SKAN Group? | SKAN Group trades under SKAN ticker. |
| When did SKAN Group go public? | SKAN Group went public in 2021. |
| Who are competitors of SKAN Group? | SKAN Group main competitors include Nakanishi, Enovis, Savaria, Cofoe Medical, Nihon Kohden, Beijing Balance Medical, MicroPort Scientific, MicroPort, El.En. Group, Integra Lifesciences. |
| What is the current market cap of SKAN Group? | SKAN Group's current market cap is $1.6B. |
| What is the current revenue of SKAN Group? | SKAN Group's last 12 months revenue is $455M. |
| What is the current revenue growth of SKAN Group? | SKAN Group revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of SKAN Group? | Current revenue multiple of SKAN Group is 3.5x. |
| What is the current EBITDA of SKAN Group? | SKAN Group's last 12 months EBITDA is $57M. |
| What is SKAN Group's EBITDA margin? | SKAN Group's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of SKAN Group? | Current EBITDA multiple of SKAN Group is 28.1x. |
| What is the current FCF of SKAN Group? | SKAN Group's last 12 months FCF is $23M. |
| What is SKAN Group's FCF margin? | SKAN Group's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of SKAN Group? | Current FCF multiple of SKAN Group is 71.0x. |
| How many companies SKAN Group has acquired to date? | SKAN Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies SKAN Group has invested to date? | SKAN Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to SKAN Group
Lists including SKAN Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




